RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bionovate Technologies Stock

Bionovate Technologies ROA 2024

Bionovate Technologies ROA

0

Ticker

BIIO

ISIN

US09074V2025

In 2024, Bionovate Technologies's return on assets (ROA) was 0, a 0% increase from the 0 ROA in the previous year.

Bionovate Technologies Aktienanalyse

What does Bionovate Technologies do?

Bionovate Technologies Corp is a biotechnology company specializing in the research, development, and marketing of innovative medical devices for the diagnosis and treatment of skin diseases. It was founded in 2017 and is headquartered in Vancouver, Canada. Bionovate Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Bionovate Technologies's Return on Assets (ROA)

Bionovate Technologies's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Bionovate Technologies's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Bionovate Technologies's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Bionovate Technologies’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Bionovate Technologies stock

What is the Return on Assets (ROA) of Bionovate Technologies this year?

The Return on Assets (ROA) of Bionovate Technologies is 0 undefined this year.

What was the ROA of Bionovate Technologies compared to the previous year?

The ROA of Bionovate Technologies has increased by 0% compared to the previous year.

What consequences do high ROA have for investors of Bionovate Technologies?

A high ROA is advantageous for investors of Bionovate Technologies, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Bionovate Technologies?

A low ROA can be unfavorable for investors of Bionovate Technologies as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Bionovate Technologies affect the company?

An increase in ROA of Bionovate Technologies can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Bionovate Technologies impact the company?

A reduction in the ROA of Bionovate Technologies can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Bionovate Technologies?

Some factors that can influence the ROA of Bionovate Technologies include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Bionovate Technologies important for investors?

The ROA of Bionovate Technologies is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Bionovate Technologies take to improve ROA?

To improve ROA, Bionovate Technologies can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Bionovate Technologies pay?

Over the past 12 months, Bionovate Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bionovate Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Bionovate Technologies?

The current dividend yield of Bionovate Technologies is .

When does Bionovate Technologies pay dividends?

Bionovate Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bionovate Technologies?

Bionovate Technologies paid dividends every year for the past 0 years.

What is the dividend of Bionovate Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bionovate Technologies located?

Bionovate Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bionovate Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bionovate Technologies from 9/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/16/2024.

When did Bionovate Technologies pay the last dividend?

The last dividend was paid out on 9/16/2024.

What was the dividend of Bionovate Technologies in the year 2023?

In the year 2023, Bionovate Technologies distributed 0 USD as dividends.

In which currency does Bionovate Technologies pay out the dividend?

The dividends of Bionovate Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bionovate Technologies

Our stock analysis for Bionovate Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bionovate Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.